Markel Group Inc. MKL
Composite 50/100; the shares have moved about 22% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Growth ranks 29/100 — a moderate mark against it.
Valuation ranks 69/100 — a moderate point in its favour. Quality ranks 54/100 — a slight point in its favour. Balance-sheet strength ranks 53/100 — a slight point in its favour.
Growth ranks 29/100 — a moderate mark against it. Momentum ranks 37/100 — a moderate mark against it.
What the company does Markel Group Inc. (MKL) is a diversified financial services and insurance company operating globally across property & casualty, specialty programs, and investment segments. It underwrites general and professional liability, workers’ compensation, marine and energy insurance, and offers credit and surety products. The company also has non-insurance businesses including building products distribution, asset management, homebuilding, and specialty manufacturing.
Key financials MKL’s profitability metrics show mixed signals: ROE 10%, ROA 2.5%, and ROCE 8.7%. Net margin is 11.1% while operating margin is -9.7%, reflecting volatility in underwriting performance. Revenue declined -16.9% year-over-year, but EPS grew 95.4%. Leverage is conservative with a Debt/Equity of 0.23 and Interest Coverage of 12.00.
Stock health The stock shows weak quality (Sideravia Quality 44.7) and growth (37.2), with moderate strength (46.7) and valuation attractiveness (71.7). Momentum is negative over 6m (-6.19%) and 12m (-6.56%), with an RSI(14) of 41.20 indicating neither overbought nor oversold conditions.
Price vs fair value The stock trades at a PREMIUM of 25.10% versus our fair-value estimate of 1413.33 and at a discount of 3.89% versus the analyst 12-month target of 1959.50. - Q2 2026 earnings missed estimates (Zacks) - Q2 sales beat expectations (StockStory) - Earnings call summary highlights ongoing volatility (Moby) - Analyst count remains at 6 with a 1959.50 target (analyst count 6.0)
Looking forward Forward P/E of 16.98 suggests moderate valuation relative to growth, though PEG is not available. The company’s diversified model and underwriting discipline remain key watchpoints amid mixed financial performance and recent earnings volatility.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-04, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.